Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.
Yang Y, Wang Y, Liu X, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Hu C, Qi SN, Li YX.
Yang Y, et al. Among authors: cao jz.
Leukemia. 2021 Jun;35(6):1671-1682. doi: 10.1038/s41375-020-01042-y. Epub 2020 Sep 17.
Leukemia. 2021.
PMID: 32943751
Free PMC article.